Secondary distal femoral osteosarcoma in a non-irradiated survivor of bilateral retinoblastoma Authors: Amine Belharty, Hind Qajia, Ahmed El Heiba Cheikh Maalainine, Amina Kili, Maria Kababri, Laila Hessissen, Nazik Allali, Latifa Chat, Siham El Haddad Published: 2026 ABSTRACT AbstractSurvivors of bilateral retinoblastoma are at significantly increased lifetime risk of secondary malignancies, particularly osteosarcoma. While radiotherapy further amplifies this risk, osteosarcoma may develop in non-irradiated patients due to underlying genetic susceptibility. A 16-year-old female was referred for evaluation of progressive left knee swelling following minor trauma. Her past medical history was significant for bilateral retinoblastoma diagnosed in infancy, managed with right eye enucleation and systemic chemotherapy, without exposure to radiotherapy. She had remained in complete remission for the past 14 years. Radiographs demonstrated heterogeneous distal femoral architecture with multilamellar periosteal reaction and soft tissue thickening. MRI revealed an aggressive metaphyso-epiphyso-diaphyseal lesion with cortical destruction, intra-articular extension, and soft tissue invasion. A separate intramedullary tibial focus suspicious for a skip metastasis was also identified. Staging showed no pulmonary metastases. Histopathological and immunohistochemical analysis confirmed conventional osteosarcoma. This case illustrates the development of secondary osteosarcoma in a non-irradiated survivor of bilateral retinoblastoma. Although genetic testing was not performed, bilateral disease strongly suggests germline RB1 mutation, a well-established risk factor for osteosarcoma. Persistent musculoskeletal symptoms in such patients warrant prompt radiologic evaluation to avoid diagnostic delay.Keywords: Bilateral retinoblastoma, Secondary osteosarcoma, RB1, Bone tumor, MRI, Pediatric oncology Introduction Retinoblastoma is the most common primary intraocular malignancy of childhood and results from biallelic inactivation of the RB1 tumor suppressor gene located on chromosome 13q14. Bilateral presentation in infancy is highly associated with a germline RB1 mutation and confers a markedly increased lifetime risk of second primary malignancies [1,2]. Among these, Osteosarcoma is the most frequently reported secondary cancer [1]. Large epidemiologic studies have demonstrated dramatically elevated standardized incidence ratios for osteosarcoma in hereditary retinoblastoma survivors compared with the general population [[1], [2], [3]]. Although external beam radiotherapy increases the risk of radiation-induced sarcomas, osteosarcoma can also arise in non-irradiated patients, reflecting intrinsic genomic instability related to RB1 dysfunction [1]. With improved survival rates of retinoblastoma patients, long-term surveillance for secondary malignancies has become increasingly relevant. Early radiologic recognition of aggressive bone lesions in genetically predisposed adolescents is essential, particularly when initial symptoms are attributed to trauma. We report a case of conventional osteosarcoma of the distal femur occurring 14 years after remission of bilateral retinoblastoma in a patient who did not receive radiotherapy, emphasizing the radiologic features and the importance of maintaining diagnostic vigilance in genetically predisposed individuals. Case presentation A 16-year-old female presented with progressive swelling of the left knee associated with functional limitation. She had a history of bilateral retinoblastoma diagnosed at 7 months of age, treated with right eye enucleation and conservative therapy of the left eye combined with systemic chemotherapy, without adjuvant radiotherapy. She achieved complete remission and remained disease-free for 14 years. No genetic testing had been performed. One month prior to presentation, she sustained minor trauma to the left knee followed by localized pain without immediate functional impairment. Ultrasound at that time demonstrated moderate suprapatellar effusion. Despite symptomatic treatment, progressive tumefaction developed over the subsequent 2 weeks, without inflammatory signs, accompanied by increasing restriction of joint mobility. Plain radiographs of the left knee demonstrated an aggressive lesion centered in the distal femoral metaphysis. The lesion exhibited heterogeneous internal matrix mineralization with areas of osteocondensation involving the medial femoral condyle. A multilamellar (“onion-skin”) periosteal reaction was evident along the medial cortex, associated with cortical irregularity and adjacent soft tissue density suggesting extraosseous extension. Mild narrowing of the femorotibial joint space was also observed (Fig. 1). The radiographic pattern was highly suspicious for a primary malignant bone tumor. Anteroposterior (A) and lateral (B) radiographs of the left knee demonstrating an aggressive distal femoral metaphyseal lesion with heterogeneous mineralization and focal osteocondensation of the medial femoral condyle associated with a multilamellar periosteal reaction (arrow). MRI of the left knee was performed for local staging. Imaging demonstrated a large, expansile intramedullary lesion centered in the distal femoral metaphysis with extension into the epiphysis and proximal diaphysis. The lesion appeared hypointense relative to muscle on T1-weighted sequences and heterogeneously hyperintense on T2-weighted and STIR sequences, with internal areas of low signal corresponding to mineralized matrix. There was clear cortical breakthrough with formation of a sizable extraosseous soft tissue mass extending into the surrounding musculature. Post-contrast sequences demonstrated heterogeneous enhancement of both intraosseous and soft tissue components. Intra-articular extension with involvement of the femorotibial joint was identified (Figs. 2A–E). MRI of the left knee. (A) Coronal T1-weighted image demonstrating a hypointense intramedullary lesion centered in the distal femoral metaphysis with extension toward the epiphysis and diaphysis. (B) Axial proton density fat-suppressed (PD FS) image showing cortical breach with periosteal reaction (arrow), extraosseous soft tissue infiltration, and associated joint effusion. (C) Sagittal PD fat-suppressed image illustrating a large soft tissue mass (arrow) arising from the distal femur with surrounding edema. (D) Sagittal contrast-enhanced T1-weighted image demonstrating intense and heterogeneous enhancement of both the intraosseous tumor and the extraosseous soft tissue component. (E) Apparent diffusion coefficient (ADC) map demonstrating low signal intensity within the lesion, consistent with restricted diffusion and high cellularity. (F) Sagittal contrast-enhanced T1-weighted image revealing a distinct enhancing intramedullary focus within the proximal tibia (arrow), separated from the primary femoral lesion, raising suspicion for a skip metastasis. Additionally, a distinct intramedullary focus of abnormal signal intensity was observed within the proximal tibial metaphysis, separated from the primary femoral lesion by normal-appearing marrow, raising suspicion for a skip metastasis (Fig. 2F). Contrast-enhanced computed tomography of the chest demonstrated no evidence of pulmonary metastases. Whole-body bone scintigraphy revealed intense focal radiotracer uptake confined to the distal left femur corresponding to the primary lesion, without evidence of distant skeletal involvement. A bone biopsy revealed a poorly differentiated malignant spindle cell proliferation with marked cytologic atypia and brisk mitotic activity. Immunohistochemical analysis confirmed the diagnosis of conventional osteosarcoma. Following histopathological confirmation, the patient underwent neoadjuvant chemotherapy consisting of adriamycin and cisplatin for 3 cycles. This was followed by surgical resection of the tumor. Postoperatively, she received 3 additional cycles of adjuvant chemotherapy with the same regimen. Discussion Survivors of bilateral retinoblastoma carry a substantial lifelong risk of secondary malignancies due to the strong association between bilateral disease and germline RB1 mutation. Loss of pRB function results in dysregulated cell cycle control, genomic instability, and increased susceptibility to sarcomagenesis [4]. Long-term follow-up studies report cumulative incidences of second malignant neoplasms ranging from 20% to 38% by adulthood [1], with osteosarcoma being the most common second primary tumor, particularly during adolescence [2,5]. Importantly, this elevated risk persists even in the absence of radiotherapy, underscoring the central role of RB1 dysfunction [1,3]. In the present case, the patient had not received radiotherapy, supporting an intrinsically driven tumorigenic mechanism rather than radiation-induced sarcoma. The latency period of 14 years between retinoblastoma remission and osteosarcoma diagnosis falls within the commonly reported range of 5-20 years [1,5]. Conventional osteosarcoma represents the most common histologic subtype and is classified as a high-grade primary bone malignancy characterized by aggressive local behavior and early metastatic potential [[6], [7], [8]]. The histologic findings in our patient were consistent with this entity and correlated with the aggressive radiologic features observed. The distal femur is the most frequent site of osteosarcoma, corresponding to areas of rapid skeletal growth [6]. Radiographic hallmarks include aggressive periosteal reaction, cortical destruction, and soft tissue mass formation, while MRI is essential for accurate local staging and assessment of intramedullary and soft tissue extension. In our case, the identification of a distinct intramedullary tibial focus on MRI raised suspicion for a skip metastasis. Skip lesions represent non-contiguous intramedullary tumor deposits separated from the primary lesion by normal marrow and are best detected by MRI, which is more sensitive than bone scintigraphy for small medullary foci. Their recognition is clinically relevant, as they may influence surgical planning and prognostic assessment. Finally, this case highlights a potential diagnostic pitfall: attributing persistent symptoms to minor trauma. In patients with bilateral retinoblastoma, ongoing bone pain or progressive swelling should prompt early advanced imaging to exclude secondary malignancy. Moreover, survivors of retinoblastoma require structured long-term follow-up due to the increased risk of secondary malignancies and the need to preserve visual function. Surveillance is primarily based on regular clinical evaluation by both an ophthalmologist and a pediatric oncologist, typically every 3 months during the first 2 years, every 6 months for the following 3 years, and annually thereafter. Conclusion Secondary osteosarcoma may occur in survivors of bilateral retinoblastoma even in the absence of prior radiotherapy. Although genetic testing was not performed, bilateral presentation in infancy is strongly associated with germline RB1 mutation, a well-established driver of secondary sarcomagenesis. This case underscores the importance of prompt imaging evaluation of persistent or progressive musculoskeletal symptoms in this high-risk population to avoid diagnostic delay and facilitate early management. Patient consent Written informed consent was obtained from the patient for the publication of this case report. Footnotes Competing Interests: The authors have declared that no competing interests exist. References